Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
BPC-157 modulates the VEGFR2 pathway to promote angiogenesis, activates the FAK-paxillin system to enhance cell migration toward injury sites, and influences nitric oxide production for improved blood flow
The system creates barriers that are structural rather than scientific
Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Support for Overall Recovery: For individuals undergoing treatment for arthritis, BPC 157 may support overall recovery by enhancing the bodys natural healing processes
US$ 29.19
US$ 25.83
US$ 21.37
US$ 29.72
US$ 29.65
US$ 29.52
US$ 27.35
US$ 26.85
US$ 23.93
